Outcome after curative resection for locally recurrent rectal cancer

Diseases of the Colon and Rectum

Volumn 49, Issue 2, 2006, Pages 175-182

  Bedrosian, Isabelle ^a   Giacco, Geoffrey ^a   Pederson, Lee ^a   Rodriguez Bigas, Miguel A ^a   Feig, Barry ^a   Hunt, Kelly K ^a   Ellis, Lee ^a   Curley, Steven A ^a   Vauthey, Jean Nicolas ^a   Delclos, Marc ^a   Crane, Christopher H ^a   Janjan, Nora ^a   Skibber, John M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Carcinoembryonic antigen; Outcome; Pelvic recurrence; Rectal cancer; Surgery

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

CANCER CONTROL; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COURSE EVALUATION; FOLLOW UP; HAZARD ASSESSMENT; HUMAN; LAPAROTOMY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PREDICTION; RECTUM CARCINOMA; RETROSPECTIVE STUDY; REVIEW; SAMPLE SIZE; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLECTOMY; COMBINED MODALITY THERAPY; FEMALE; GENES, BCL-2; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 32344441586     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-005-0276-5     Document Type: Review

References (34)

1. Anonymous 1997 Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial N Engl J Med 336 980 987
2. E Kapiteijn CA Marijnen ID Nagtegaal 2001 Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 638 646
3. TA Rich JM Skibber JA Ajani 1995 Preoperative infusional chemoradiation therapy for stage T3 rectal cancer Int J Radiat Oncol Biol Phys 32 1025 1029
4. SJ Stryker KD Kiel A Rademaker JM Shaw GT Ujiki SM Poticha 1996 Preoperative "chemoradiation" for stages II and III rectal carcinoma Arch Surg 131 514 518
5. J Garcia-Aguilar E Hernandez de Anda P Sirivongs SR Lee RD Madoff DA Rothenberger 2003 A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision Dis Colon Rectum 46 298 304
6. S Pucciarelli ML Friso P Toppan 2000 Preoperative combined radiotherapy and chemotherapy for middle and lower rectal cancer: preliminary results Ann Surg Oncol 7 38 44
7. RS Chari DS Tyler MS Anscher 1995 Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum Ann Surg 221 778 786
8. PM Sagar JR Pemberton 1996 Surgical management of locally recurrent rectal cancer Br J Surg 83 293 304
9. AM Lowy TA Rich JM Skibber RA Dubrow SA Curley 1996 Preoperative infusional chemoradiation. Selective intraoperative radiation and resection for locally advanced pelvic recurrence of colorectal adenocarcinoma Ann Surg 223 177 185
10. CR Shumate TA Rich JM Skibber JA Ajani DM Ota 1993 Preoperative chemotherapy and radiation therapy for locally advanced primary and recurrent rectal carcinoma. A report of surgical morbidity Cancer 71 3690 3696
11. WL Law KW Chu 2000 Resection of local recurrence of rectal cancer: results World J Surg 24 486 490
12. LB Harrison BD Minsky WE Enker 1998 High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer Int J Radiat Oncol Biol Phys 42 325 330
13. K Suzuki RR Dozois RM Devine 1996 Curative reoperations for locally recurrent rectal cancer Dis Colon Rectum 39 730 736
14. D Hahnloser H Nelson LL Gunderson 2003 Curative potential of multimodality therapy for locally recurrent rectal cancer Ann Surg 237 502 508
15. CG Willett PC Shellito JE Tepper R Eliseo K Convery WC Wood 1991 Intraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma Cancer 67 1504 1508
16. K Yamada T Ishizawa K Niwa Y Chuman S Akiha T Aikou 2001 Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer Br J Surg 88 988 993
17. F Lopez-Kostner VW Fazio A Vignali LA Rybicki IC Lavery 2001 Locally recurrent rectal cancer: predictors and success of salvage surgery Dis Colon Rectum 44 173 178
18. JC Salo PB Paty J Guillem BD Minsky LB Harrison AM Cohen 1999 Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience Ann Surg Oncol 6 171 177
19. M Shoup JG Guillem KM Alektiar 2002 Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy Dis Colon Rectum 45 585 592
20. SH Meterissian JM Skibber GG Giacco AK el-Naggar KR Hess TA Rich 1997 Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival Surgery 121 479 487
21. IO Baas JW Mulder GJ Offerhaus B Vogeistein SR Hamilton 1994 An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms J Pathol 172 5 12
22. FR Spitz GG Giacco K Hess 1997 p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer Clin Cancer Res 3 1685 1690
23. S Cascinu F Graziano V Catalano 2002 An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumor recurrence and event-free survival of patients treated with adjuvant chemoradiation Br JCancer 86 744 749
24. O Schwandner TH Schiedeck HP Bruch M Duchrow U Windhoevel R Broil 2000 p53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer Eur J Cancer 36 348 356
25. M Diez JM Enriquez J Carnunas 1995 Prediction of recurrence in B-C stages of colorectal cancer by p53 nuclear overexpression in comparison with standard pathological features Eur J Surg Oncol 21 635 639
26. S Buglioni I D'Agnano M Cosimelli 1999 Evaluation of multiple biopathological factors in colorectal adenocarcinornas: independent prognostic role of p53 and bcl-2 Int J Cancer 84 545 552
27. D Hockenbery G Nunez C Milliman RD Schreiher 1990 Korsmeyer. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death Nature 348 334 336
28. C Rodel GG Grabenhauer T Papadopoulos 2002 Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer Int J Radiat Oncol Biol Phys 52 294 303
29. NK Kim JK Park KY Lee 2001 p53, BCL-2, and Ki-67 expression according to tumor response after concurrent chernoradiotherapy for advanced rectal cancer Ann Surg Oncol 8 418 424
30. T Wiggers GH Mannaerts AW Marinelli H Martijn HJ Rutten 2003 Surgery for locally recurrent rectal cancer Colorectal Dis 5 504 507
31. J Garcia-Aguilar JW Cromwell C Marra SH Lee RD Madoff DA Rothenberger 2001 Treatment of locally recurrent rectal cancer Dis Colon Rectum 44 1743 1748
32. B Rau I Sturm H Lage 2003 Dynamic expression profile of p21 WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy J Clin Oncol 21 3391 3401
33. B Glimelius 2003 Recurrent rectal cancer. The pre-irradiated primary tumour: can more radiotherapy be given? Colorectal Dis 5 501 503
34. M Mohiuddin G Marks J Marks 2002 Long-term results of reirradiation for patients with recurrent rectal carcinoma Cancer 95 1144 1150